Patent intelligence · US
US 10631559
Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-(3S,6S)-
Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-(3S,6S)-
Patent details — US 10631559
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 28, 2020
- Expiration
- Apr 23, 2040
- Applicant
- SUNTORY BEVERAGE & FOOD ASIA PTE. LTD.
- Claims
- 17
- CPC classes
- A61P, A61P25/00, A61P25/24, A61P25/28
Quick answer
US 10631559 (Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-(3S,6S)-) is held by SUNTORY BEVERAGE & FOOD ASIA PTE. LTD.. Status: granted. Granted Apr 28, 2020. Expires Apr 23, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SUNTORY BEVERAGE & FOOD ASIA PTE. LTD.
- Grant date
- Expiration
- Claims
- 17
- CPC classes
- A61P, A61P25/00, A61P25/24, A61P25/28
More from SUNTORY BEVERAGE & FOOD ASIA PTE. LTD.
Related pharmaceutical patents in our USPTO index.
-
US 12403164
Lentiviral vector formulations
granted -
US 12403183
Factor VIII polypeptide formulations
granted -
US 12391750
Anti-C1S antibodies and methods of use thereof
granted -
US 12371747
Methods of reducing immunogenicity against factor VIII in individuals undergoing factor VIII therapy
granted -
US 12364774
Nucleic acid molecules and uses thereof for non-viral gene therapy
granted -
US 12268688
Compositions and methods of use for modified release minoxidil
granted -
US 12257288
Methods of inducing immune tolerance to clotting factors
granted -
US 12240917
Anti-complement C1s antibodies and uses thereof
granted
Frequently asked questions
What is US patent 10631559?
US 10631559 (Acidic extracts and beverages containing 2,5-piperazinedione,3,6-bis(phenylmethyl)-(3S,6S)-) is held by SUNTORY BEVERAGE & FOOD ASIA PTE. LTD.. Status: granted. Granted Apr 28, 2020. Expires Apr 23, 2040 (14 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10631559?
SUNTORY BEVERAGE & FOOD ASIA PTE. LTD. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 140 pharmaceutical patents for this assignee.
When does US 10631559 expire?
Our index shows an expiration date of Apr 23, 2040 (14 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.